Nevertheless, there are contradictory data addressing the downregulation of lncRNA NEAT1 and its contribution to the correction of NAFLD in rats via the mTOR/S6K1 signaling pathway [24]. This evidence concerns the gene RPS6KB1 and metabolic dysfunction-associated steatotic liver disease.